Roche Holding AG RHHBY
60.62 USD +1.45 (+2.45%)
Nov 4, 2026, 11:37 AM EST
59.92 Day range 60.62
40.50 52-week range 61.27
- YTD
- +17.55%
- 1 year
- +49.68%
- Market cap
- 386.40B
- EPS (ttm)
- 2.41
- P/E ratio
- 25.15
- YTD return
- +17.55%
- 1-year return
- +49.68%
- Volume
- 22.64K
- Avg volume
- 1.79M
- Open
- 60.29
- Previous close
- 59.17
- Day's range
- 59.92 – 60.62
- 52-week range
- 40.50 – 61.27
- Earnings date
- Feb 4, 2027
2Y +20.84 (+52.85%)
Next earnings
Feb 4, 2027
Expected Feb 4, 2027. Consensus EPS estimate 1.49.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2027 | Dec 30, 2026 | 1.49 | — | — | — |
| Jul 23, 2026 | Jun 30, 2026 | 1.58 | 1.66 | +0.08 | +5.06% |
| Jan 29, 2026 | Dec 31, 2025 | 1.35 | 1.36 | +0.01 | +0.74% |
| Jul 24, 2025 | Jun 30, 2025 | 1.62 | 1.74 | +0.12 | +7.41% |
| Jan 30, 2025 | Dec 31, 2024 | 1.17 | 1.18 | +0.01 | +0.85% |
| Jul 22, 2024 | Jun 30, 2024 | 1.30 | 1.43 | +0.13 | +10.00% |
News
Roche receives FDA 510(k) clearance for new cobas® eplex respiratory pathogen panel 3, enabling labs to customize respiratory testing for local patient needs 
Roche: Valuation Leaves Limited Upside 
Brown Advisory Flexible Equity Strategy: Q3 2026 Top Contributors And Detractors 
Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma 
Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories 
Billions in New Plants, Trillions in Potential Obesity-Drug Revenue Over Two Decades 
Breakfast News: Science Strikes Back at Cancer 
Roche Targets Emerging Oncology Market With New Lung-Cancer Drug 
Roche says divarasib cut risk of death 44% in lung cancer trial 
Genentech's Divarasib Demonstrated Best-in-Class Efficacy, Advancing the Standard of Care in Previously Treated KRAS G12C-mutated Lung Cancer
Your note
Sign in to keep a note on RHHBY — it syncs with the Stock Master app.